Back to News
Market Impact: 0.6

Jefferies initiates Philip Morris stock with Buy rating, $220 price target

PMUBS
Company FundamentalsAnalyst InsightsAnalyst EstimatesCorporate Guidance & OutlookCorporate EarningsCapital Returns (Dividends / Buybacks)Regulation & LegislationCurrency & FX
Jefferies initiates Philip Morris stock with Buy rating, $220 price target

Philip Morris (PM) is drawing strong analyst confidence, with Jefferies initiating a Buy rating and $220 price target, citing the company's leading position in heated tobacco and oral nicotine, robust financials, and superior growth outlook versus broader blue-chip stocks. This follows PM's reaffirmation of its 2025 EPS forecast of $7.01-$7.14, reflecting a strategic focus on expanding its smoke-free portfolio, which has contributed to the stock's 50% year-to-date gain. While some analyses indicate PM may be trading above its fair value, the consensus among key firms like BofA and Stifel remains largely positive, emphasizing its strategic pivot and shareholder return potential.

Analysis

Philip Morris is experiencing strong bullish sentiment from analysts, led by a new 'Buy' rating from Jefferies with a $220 price target. This optimism is founded on the company's dominant position in the high-growth heated tobacco and oral nicotine pouch segments, which are expected to drive sustainable high single-digit EBIT expansion. The company's financial health is robust, supported by impressive gross profit margins of 65.7% and a commitment to elevated shareholder cash returns. While the stock has seen a significant 50% year-to-date return and trades near its 52-week high, Jefferies suggests its valuation is not excessive when compared to Food and Personal Care blue chips, a peer group against which PM offers superior growth prospects. This outlook is reinforced by the company's reaffirmed 2025 EPS forecast of $7.01-$7.14, representing 10.5% to 12.5% currency-neutral growth. Other firms, including BofA Securities and Stifel, also hold 'Buy' ratings, citing the strategic pivot to smoke-free products. However, a note of caution is warranted, as UBS maintains a 'Neutral' rating with a $170 target, and an InvestingPro analysis indicates the stock may be trading above its intrinsic fair value.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.